[New testis tumor study AH 09/03/XX--darbepoetin activated].
Rexer
H
H
Geschäftsstelle der AUO. auo@meckevidence.de
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage*; D000068256:Darbepoetin alfa; D004338:Drug Combinations; D004921:Erythropoietin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005047:Etoposide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D011379:Prognosis; D013736:Testicular Neoplasms / Q000150:complications* / Q000188:drug therapy*; D016896:Treatment Outcome
D004338:Drug Combinations; D001761:Bleomycin; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D005047:Etoposide; D002945:Cisplatin